Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3A Diagnostics is a German biotechnology company specializing in the development of innovative point-of-care diagnostic tools for the rapid detection of infectious diseases. The company's core technology involves enzyme-activated biosensors that provide immediate visual or digital results without the need for complex laboratory equipment. Their flagship product, PerioSafe, is designed for the early detection of periodontal inflammation by identifying specific biomarkers in oral fluid. 3A Diagnostics focuses on bridging the gap between professional clinical diagnostics and patient-led monitoring, particularly in the dental and infectious disease sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3A Diagnostics & Pharmaceuticals.